Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)

Clinical trial NCT01567813 · COMPLETED

Trial details

NCT number: NCT01567813
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Human Papilloma Virus Infection

Start date: 2011-06-23
Primary completion: 2019-06-01
Enrollment: 114035

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.